Xact Robotics wins CE Mark for robotic nav & steering system, raises $5m in Series C

Xact Robotics said today it won CE Mark approval in the European Union for its robotics navigation and steering system designed for image-guided percutaneous procedures, and said it raised $5 million in a Series C round of financing. The Caesarea, Israel-based company said its Xact robotics system was cleared for use in planning and accessing targets in the abdomen during computed-tomography-guided percutaneous procedures. The system allows the physician to plan the procedure by selecting a target and entry point, after which the platform recommends a trajectory and verification checkpoints along the trajectory. Once approved by the operator, the user can attach the appropriate tool to the robot to allow it to perform needle insertion and steering according to the plan, the company said. The Xact platform compensates for breathing and patient movement during the procedure for better accuracy and safety, Xact said. “Currently, manual navigation of needles for biopsies and needle-based tools for procedures such as abscess drainage and tumor ablation, which are guided by imaging technologies, requires a high level of expertise and presents multiple challenges such as the need to construct a precise needle trajectory in 3D to avoid damaging critical intervening structures while simultaneously needing to compensate for target movement due to patient movements or breathing. Xact’s solution has thus far demonstrated the potential to successfully addresses these challeng...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Regulatory/Compliance Robotics Surgical xactrobotics Source Type: news